BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
85 hedge funds and large institutions have $74M invested in BioDelivery Sciences International, Inc. in 2016 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 23 reducing their positions, and 14 closing their positions.
266% more call options, than puts
Call options by funds: $1.01M | Put options by funds: $277K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
0% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 23
3% less funds holding
Funds holding: 88 → 85 (-3)
5% less capital invested
Capital invested by funds: $78.2M → $74M (-$4.23M)
21% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.06M |
| 2 |
BGA
Belmont Global Advisors
Dallas,
Texas
|
+$1.08M |
| 3 |
William Blair & Company
Chicago,
Illinois
|
+$546K |
| 4 |
Morgan Stanley
New York
|
+$533K |
| 5 |
SC
Searle & Co
Greenwich,
Connecticut
|
+$468K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$6.26M |
| 2 |
Renaissance Technologies
New York
|
-$1.99M |
| 3 |
Millennium Management
New York
|
-$1.7M |
| 4 |
FPC
Falcon Point Capital
San Francisco,
California
|
-$1.53M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$1.05M |
BDSI Hedge Fund Activity: Q3 2016 in Review
85 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q3 2016, worth a combined $74M — down 5.4% from $78.2M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of BDSI and 11 opened new positions — a net loss of 3 holders — while 23 trimmed existing stakes and 23 added.
The largest buyer was Ameriprise, adding an estimated $2.06M. The largest seller was Armistice Capital, exiting entirely with an estimated $6.26M sold.
- 85 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q3 2016, down from 88 in Q2 2016.
- Funds reported $74M of BioDelivery Sciences International, Inc. stock for Q3 2016, down 5.4% quarter-over-quarter.
- 11 funds opened new BioDelivery Sciences International, Inc. positions in Q3 2016 and 14 closed out, a net change of -3 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q3 2016 was Ameriprise, an estimated $2.06M added.
- The largest BioDelivery Sciences International, Inc. seller in Q3 2016 was Armistice Capital, an estimated $6.26M sold.
Based on aggregated 13F filings for Q3 2016.